| Literature DB >> 29125230 |
Amir M Owrangi1, Donald A Roberts1, Elizabeth L Covington1, James A Hayman1, Kathryn M Masi1, Choonik Lee1, Jean M Moran1, Joann I Prisciandaro1.
Abstract
Entities:
Year: 2017 PMID: 29125230 PMCID: PMC5689918 DOI: 10.1002/acm2.12191
Source DB: PubMed Journal: J Appl Clin Med Phys ISSN: 1526-9914 Impact factor: 2.102
The estimated fetal doses with and without the fetal shield based on the measured clinical plans listed in Table 2. A distance of 50 cm was maintained between the CT reference and the ion chamber used for these measurements, as shown in Fig. 2(a). The distance displayed in this Table is the measured distance between the center of the PTV and the ion chamber for each clinical setup
| Distance (cm) | Total PTV (or CAX) dose (Gy) | PD without shield (cGy) | PD with shield (cGy) | |
|---|---|---|---|---|
| Brain 3D | 50 | 54 | 0.81 | 0.70 |
| Brain 3D FFF | 50 | 54 | 0.65 | 0.59 |
| Brain IMRT | 50 | 54 | 3.19 | 2.21 |
| Brain VMAT | 50 | 54 | 2.27 | 1.73 |
| Whole brain | 50 | 30 | 2.16 | 1.98 |
| Head and neck 3D | 40 | 66 | 7.33 | 4.95 |
| Head and neck IMRT | 40 | 66 | 18.35 | 17.03 |
| Head and neck VMAT | 40 | 66 | 11.15 | 10.69 |
| LUL 3D | 30 | 60 | 7.02 | 5.10 |
| LUL IMRT | 30 | 60 | 8.28 | 5.04 |
LUL, left upper lobe of lung.